Last Updated on October 6, 2024 by The Health Master
Mumbai: Global pharma major Lupin announced on Tuesday that it has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Goa manufacturing facility after its inspection in September 2021.
The USFDA has classified the facility as Voluntary Action Indicated (VAI), which probably hints towards closure of inspection being run by the regulatory authority.
Lupin’s Goa facility came under USFDA’s scanner after regulatory compliance issues were reported and since then it has been under its inspection.
The US FDA had earlier issued seven observations after inspecting the Goa manufacturing facility, the major exporter of the products manufactured by Lupin.
Commenting on the development, Vinita Gupta, CEO, Lupin said “We are very happy to have received the EIR from the USFDA with VAI classification for our Goa plant.
This is a significant milestone as we build back our reputation of being best-in-class in quality and compliance. We are committed to manufacture and supply products of the highest quality from all our manufacturing sites.”
Speaking on the importance of EIR for Goa’s manufacturing facility, Nilesh Gupta, Managing Director, Lupin said “This is a very positive development and we are delighted with the news of the change in classification of our Goa site.
The Goa site has a very important place in the U.S. market with the number of affordable, quality medicines we supply, and we now look forward to new products flowing out of the site again.
We remain committed to meet and exceed global standards of quality and compliance at all our manufacturing facilities globally.”
Lupin is the third largest pharmaceutical company in the US by prescriptions with over 15 manufacturing sites, seven research centres, more than 20,000 professionals working globally.
USFDA approves Eye Drops that could replace reading glasses
Zydus Cadila gets USFDA nod for generic Schizophrenia drug
Alembic gets USFDA tentative nod for drug for high BP
Biocon gets USFDA nod for Mycophenolic Acid
Morepen gets USFDA nod for anti-allergy drug
NDPS: 9 arrested for selling drugs
Hindustan Syringes and Medical Devices allowed to restart production
Action sought against Hetero Pharma: HRF
KSRPA asks Govt to amend Rule 123 of D&C Rules w.r.t. Schedule K
USFDA approves Eye Drops that could replace reading glasses
Drug recall: Lupin recalls 4,113 cartons of oral contraceptive
Inquiry needed into unfair trade practice of discount pricing by Medical…
Increase in Pharmacy colleges to meet rising demand of Medical Stores
Procedure for registration of Medical Devices: CDSCO
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
